Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have been assigned an average rating of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $20.40.

A number of equities analysts recently commented on the stock. Zacks Investment Research lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, May 10th. Citigroup Inc. reaffirmed a “buy” rating and issued a $17.00 price objective (down previously from $28.00) on shares of Surgery Partners in a research note on Friday, August 11th. Stifel Nicolaus lowered shares of Surgery Partners from a “hold” rating to a “sell” rating and decreased their price objective for the stock from $21.00 to $17.00 in a research note on Wednesday, August 9th. BidaskClub raised shares of Surgery Partners from a “hold” rating to a “buy” rating in a research note on Wednesday, June 21st. Finally, Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Surgery Partners in a research note on Wednesday, August 9th.

Surgery Partners (NASDAQ SGRY) traded down 1.69% during mid-day trading on Wednesday, reaching $8.75. 311,223 shares of the company’s stock were exchanged. Surgery Partners has a 1-year low of $8.52 and a 1-year high of $24.05. The stock has a market capitalization of $427.10 million, a PE ratio of 57.57 and a beta of 1.71. The firm’s 50-day moving average is $16.70 and its 200 day moving average is $19.53.

A number of large investors have recently added to or reduced their stakes in SGRY. Bank of Montreal Can bought a new stake in Surgery Partners during the first quarter worth about $120,000. Voya Investment Management LLC bought a new stake in Surgery Partners during the second quarter worth about $222,000. Atria Investments LLC bought a new stake in Surgery Partners during the first quarter worth about $203,000. Royal Bank of Canada increased its stake in Surgery Partners by 680.5% in the second quarter. Royal Bank of Canada now owns 10,544 shares of the company’s stock worth $240,000 after buying an additional 9,193 shares during the last quarter. Finally, American International Group Inc. increased its stake in Surgery Partners by 7.1% in the first quarter. American International Group Inc. now owns 11,462 shares of the company’s stock worth $224,000 after buying an additional 759 shares during the last quarter. Institutional investors own 38.06% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/surgery-partners-inc-sgry-receives-20-40-consensus-price-target-from-brokerages/1528490.html.

Surgery Partners Company Profile

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.